Policy Turning Point | Brockman Stakes | SpaceX Index Surge

The mood flipped quickly at the open. Selling paused, and buyers leaned in.

Futures climbed across the board. Nasdaq set the pace with early strength. The S&P followed, steady but controlled.

WTI slipping toward $104 changed the feel. That took pressure off risk in one move. Energy cooled, and stocks caught a bid.

Earnings helped keep the lift intact. Good numbers gave traders something to trust.

The bounce came easy, but not deep.

Investor Signal 

This is breathing room, not a new trend. Oil stepping back made the difference. Equities are still reacting, not driving. Confidence is building, but not locked in.

The headlines are loud right now—oil, volatility, uncertainty.

But while attention shifts, something else keeps working quietly in the background.

An overlooked investment that’s compounded at an extraordinary rate over time.

Most people never even look at it.

Learn how it works here

All earnings season, the question has been the same. Companies are spending billions on AI. But where is the actual revenue? Last night, Palantir (PLTR) answered that question clearly.

Palantir reported 85 percent revenue growth in Q1, its fastest pace since going public in 2020. U.S. government revenue rose 84 percent. U.S. commercial revenue rose 133 percent. The company then raised its full-year guidance well above what analysts expected.

CEO Alex Karp linked the government acceleration directly to the Iran war. Palantir's AI tools are being used in active military operations right now. That is not a future use case. It is a current billing line.

What the Numbers Say

The stock falling despite those numbers is not a bad sign for AI software. 

The Proof

AI software revenue is accelerating below the hyperscaler level. If Salesforce follows Palantir's trajectory when it reports, the enterprise AI category gets repriced upward. ServiceNow already showed the risk when the Gulf slowdown hit its bookings, Palantir's government acceleration is the counter-evidence.

Anthropic announced a $1.5 billion joint venture Monday morning to sell AI into private equity portfolio companies. By Monday evening, reports surfaced that OpenAI had already finalized its own version. The price tag is $10 billion, more than six times larger.

Both ventures are designed to do the same thing. Private equity firms own thousands of mid-size businesses across healthcare, manufacturing, and retail. Those businesses need AI implementation help and have cost-cutting pressure. Both labs want to be the ones who show up and do the work.

Anthropic moved first with the strongest PE names. Blackstone (BX) and Goldman Sachs (GS) are committed partners. OpenAI is responding with TPG, Brookfield, and Bain Capital at six times the scale.

The size gap reveals the strategy gap. Anthropic is moving precisely. OpenAI is trying to overpower a head start it does not have.

Both companies need enterprise revenue before their IPO windows open. Anthropic is targeting October. OpenAI is targeting later this year. The first JV to name a real portfolio company with real cost savings wins the narrative heading into both offerings.

The Race

The lab that closes a named deal first with measurable results owns the enterprise AI story. Right now that race has no leader.

The reclusive Oregon forecaster who accurately predicted both the 2008 banking collapse and the post-2020 inflation crisis says a huge event is coming to America this month. 

He's warning that very soon, life in America is going to take a strange and dangerous turn... See his warning here - before it's too late.

Trump revoked Biden's AI safety executive order on his first day in office in 2025. His entire posture toward AI has been hands-off and deregulatory. That posture is now changing, and the reason has a specific name.

Anthropic's Mythos model triggered the reversal. Cybersecurity experts warned that Mythos could supercharge complex cyberattacks at an unprecedented scale. That warning reached the White House and shifted the calculation.

The administration is now considering a formal government review process for new AI models before they are released publicly.

What's in Play

For Anthropic, the tension is specific. Mythos is its most powerful commercial product. It is also now the reason regulators are reconsidering the entire oversight framework.

The threshold that triggers review matters enormously. Whatever capability level gets named in any executive order becomes the ceiling every AI lab races toward and stops just short of.

The Ceiling

That number does not exist yet. When it does, it becomes the most important line in the AI industry for the next decade.

Greg Brockman testified in the Musk v. OpenAI trial. Two disclosures stood out immediately and neither had been public before.

First, Brockman's stake in OpenAI is worth close to $30 billion. Second, in 2017, Sam Altman gave Brockman a percentage of his personal family office, worth $10 million at the time. Musk was not informed of that arrangement.

Brockman also disclosed equity stakes in Cerebras, an AI chip company OpenAI is now buying chips from, and Helion Energy, a startup Altman has separately invested in heavily.

Musk's lawyers are using this financial web to argue Brockman's loyalty ran to Altman personally, not to OpenAI's nonprofit mission. The settlement text Musk sent two days before trial was formally entered into evidence. 

OpenAI's lawyers argue that the text proves Musk's motive is competitive destruction, not mission protection.

The Prospectus Problem

A $30 billion personal stake and undisclosed financial ties between OpenAI's two top executives will need a full explanation in the IPO prospectus. The jury decides the legal question. Investors decide the valuation one.

The President of the United States once went to bat for an American energy company that's merging energy and AI.

It's wildly cheap, and one man believes it could be the long-term answer to our AI energy needs.

Click here to unlock details on this value play.

Most companies that go public have to wait three months before joining major stock indexes. A new Nasdaq rule changed that. Now large companies can join the Nasdaq 100 just 15 days after their IPO.

The rule was designed specifically to attract SpaceX's listing.

Here is why that matters. Every fund that tracks the Nasdaq 100, including the QQQ, the third-largest ETF in the world, is required to buy whatever is in the index. When SpaceX joins 15 days after its IPO, every one of those funds becomes a forced buyer at whatever price the market sets.

Small float plus forced buying plus retail demand for Elon Musk's rocket company equals a post-IPO price that has very little to do with SpaceX's actual business.

The Spike

Early investors face a real choice. Sell in the IPO before index buying inflates the price. Or hold through the lock-up and sell into a wave of forced demand. One of those outcomes is significantly better than the other.

AI revenue is real. Palantir proved it. The race to capture enterprise AI is on. Anthropic and OpenAI proved that. And SpaceX's IPO mechanics mean the largest offering in history may trade on index rules more than fundamentals.

The money is moving. The structures are being built. The prices come later.